1 document found, page 1 of 1

Sort by Issue Date

Intravenous Busulfan for Autologous Stem Cell Transplantation in Adult Patients...

Nagler, A; Labopin, M; Gorin, NC; Ferrara, F; Sanz, M; Wu, D; Gomez, A; Lapusan, S; Irrera, G; Guimaraes, J; Botelho de Sousa, A; Carella, A; Vey, N

Oral busulfan is the historical backbone of the busulfan+cyclophosphamide regimen for autologous stem cell transplantation. However intravenous busulfan has more predictable pharmacokinetics and less toxicity than oral busulfan; we, therefore, retrospectively analyzed data from 952 patients with acute myeloid leukemia who received intravenous busulfan for autologous stem cell transplantation. Most patients were...


1 Results

Queried text

Refine Results

Author



















Date


Document Type


Access rights


Resource


Subject